These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19033289)

  • 1. Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin).
    Georgopoulos M; Polak K; Prager F; Prünte C; Schmidt-Erfurth U
    Br J Ophthalmol; 2009 Apr; 93(4):457-62. PubMed ID: 19033289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe intraocular inflammation after intravitreal injection of bevacizumab.
    Sato T; Emi K; Ikeda T; Bando H; Sato S; Morita S; Oyagi T; Sawada K
    Ophthalmology; 2010 Mar; 117(3):512-6, 516.e1-2. PubMed ID: 20031229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and characteristics of acute intraocular inflammation after intravitreal injection of bevacizumab: a retrospective cohort study.
    Johnson D; Hollands H; Hollands S; Sharma S
    Can J Ophthalmol; 2010 Jun; 45(3):239-42. PubMed ID: 20436545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration.
    Wickremasinghe SS; Michalova K; Gilhotra J; Guymer RH; Harper CA; Wong TY; Qureshi S
    Ophthalmology; 2008 Nov; 115(11):1911-5. PubMed ID: 18672291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection.
    Aggio FB; Farah ME; de Melo GB; d'Azevedo PA; Pignatari AC; Höfling-Lima AL
    Eye (Lond); 2007 Mar; 21(3):408-9. PubMed ID: 17277758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of sterile intraocular inflammatory responses after intravitreal bevacizumab injection.
    Chong DY; Anand R; Williams PD; Qureshi JA; Callanan DG
    Retina; 2010 Oct; 30(9):1432-40. PubMed ID: 20559156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China.
    Wang F; Yu S; Liu K; Chen FE; Song Z; Zhang X; Xu X; Sun X
    Ophthalmology; 2013 Feb; 120(2):355-61. PubMed ID: 23084126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch.
    Yamashiro K; Tsujikawa A; Miyamoto K; Oh H; Otani A; Tamuara H; Ooto S; Sasahara M; Iwama D; Yoshimura N
    Retina; 2010 Mar; 30(3):485-90. PubMed ID: 19952993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectivity and safety of bevacizumab intravitreal injections for exudative age-related macular degeneration treatment--6 months observations].
    Małgorzata F
    Klin Oczna; 2010; 112(7-9):213-6. PubMed ID: 21121123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab for treatment of uveitic macular edema.
    Cordero Coma M; Sobrin L; Onal S; Christen W; Foster CS
    Ophthalmology; 2007 Aug; 114(8):1574-1579.e1. PubMed ID: 17363060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous web after pars plana vitrectomy and bevacizumab with fluid-air exchange.
    Chiang A; Reddy S; Tsui I; Hubschman JP
    Semin Ophthalmol; 2011 Jan; 26(1):25-7. PubMed ID: 21275601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration.
    Landa G; Amde W; Doshi V; Ali A; McGevna L; Gentile RC; Muldoon TO; Walsh JB; Rosen RB
    Ophthalmologica; 2009; 223(6):370-5. PubMed ID: 19590252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveitis following intravitreal bevacizumab: a non-infectious cluster.
    Kay CN; Tarantola RM; Gehrs KM; Folk JC; Mahajan VB; Boldt HC; Syed NA; Russell SR
    Ophthalmic Surg Lasers Imaging; 2011; 42(4):292-6. PubMed ID: 21800802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A; Stinnett S; Fekrat S
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.